The U.S. Food and Drug Administration (FDA) is coming for any physician or pharmacy that promotes ivermectin as a drug that can “prevent Coronavirus Disease 2019,” or COVID-19. Recently, America’s drug regulatory agency claims they received complaints that the antiparasitic drug off-label can treat the novel coronavirus at the same dose used for authorized treatments, writes FDA Acting Branch Chief Branch Shannon Glueck, PharmD. This letter was sent to Humayun J. Chaudhry, DO, MS, FACP, FACOI, President and Chief Executive Officer Federation of State Medical Boards.
As a signal that the FDA will start enforcing actions against individuals and groups positioning or making claims that ivermectin is an effective treatment for COVID-19, the letter calls out that “the FDA has neither authorized nor approved any ivermectin drug product for use in preventing or treating COVID-19. Although clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing, currently available data do not show that ivermectin is safe or effective for the prevention or treatment of COVID-19.”
Referring to some of its previous announcements, d...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).